Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, December 18, 2014
 
Register | Sign in
Home Page>Products
  Product News
Highly Versatile Single Tube Code Reader
Friday, December 05, 2014
The Tracxer TS201 MINI designed to enhance users lab space.

Fast GC Add-on for IONICON PTR-TOF Instruments
Friday, December 05, 2014
Gas Chromatographic separation now combined with real-time trace gas analysis.

BioTek Introduces Cytation™ 5 Cell Imager at ASCB 2014
Thursday, December 04, 2014
ASCB 2014 Conference and Exhibition to be held December 6-10 in Philadelphia, Pennsylvania.

Limited Time Sale from Bibby Scientific
Thursday, December 04, 2014
Web Shop offers savings of up to 15% on all laboratory equipment.

One Lambda's New RUO NXType Kit Available
Thursday, December 04, 2014
The new kit is a complete solution for HLA typing by NGS.

TGAC Understanding Life on Earth
Thursday, December 04, 2014
The Genome Analysis Centre (TGAC) uses Intel-powered super computers to collect and crunch complex data that is shaping the future of science.

IDT and Ubiquitome Partner to Develop Mobile Ebola Test
Wednesday, December 03, 2014
Handheld, battery-powered Freedom4 enables rapid field deployment of gold standard molecular test.

Consistent Embryoid Body Formation and Differentiation from Stem Cells
Tuesday, December 02, 2014
Cultrex® Embryoid Body Formation Kit from AMSBIO.

Sophisticated HIV Diagnostics Adapted for Remote Areas
Tuesday, December 02, 2014
New tool is low-cost, with no electricity needed - NIH study.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 10722
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn